Global Coronary Stent Market

Coronary Stent Market Size, Share, Growth Analysis, By Product Type(Bare Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS)), By Biomaterial(Biomaterials, Polymeric Biomaterials, and Natural Biomaterials), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2668 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 63 | Figures: 75

Coronary Stent Market Dynamics

Coronary Stent Market Drivers

Increasing Prevalence of Cardiovascular Diseases

  • The rising incidence of cardiovascular diseases, including coronary artery disease, is a major driver for the global coronary stent market. Lifestyle changes, unhealthy diets, and sedentary lifestyles contribute to the growing burden of cardiovascular diseases globally.

Growing Aging Population

  • The aging population is more susceptible to cardiovascular conditions, leading to a higher demand for coronary stents. As the global population continues to age, the prevalence of cardiovascular diseases is expected to increase, driving the demand for coronary stents.

Coronary Stent Market Restraints

Stringent Regulatory Approval Processes

  • The stringent regulatory approval processes imposed by regulatory authorities can pose challenges for market growth. Manufacturers must comply with safety and efficacy assessments, which can be time-consuming and resource-intensive, delaying the market entry of new products.

Potential Complications

  • Stent implantation carries certain risks and potential complications, such as stent thrombosis, restenosis, and allergic reactions. These complications may affect patient outcomes and increase concerns among healthcare providers and patients, impacting market growth.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Coronary Stent Market size was valued at USD 9.09 Billion in 2022 and is poised to grow from USD 9.39 Billion in 2023 to USD 12.17 Billion by 2031, at a CAGR of 3.3% during the forecast period (2024-2031).

The global coronary stents market is highly competitive and characterized by the presence of several key players. These players compete based on factors such as product portfolio, technological advancements, pricing strategies, and market reach. The market is driven by continuous research and development efforts aimed at introducing innovative stent designs, improving drug-eluting capabilities, and enhancing biocompatibility. Market players focus on strategic collaborations, partnerships, and mergers and acquisitions to expand their market presence and gain a competitive edge. 'Abbott Laboratories (US)', 'Medtronic plc (Ireland)', 'Boston Scientific Corporation (US)', 'Terumo Corporation (Japan)', 'B. Braun Melsungen AG (Germany)', 'Johnson & Johnson (US)', 'Cook Medical Inc. (US)', 'C. R. Bard, Inc. (US)', 'Biosensors International Group, Ltd. (Singapore)', 'Meril Life Sciences Pvt. Ltd. (India)', 'MicroPort Scientific Corporation (China)', 'Biotronik SE & Co. KG (Germany)', 'Stentys SA (France)', 'Hexacath (France)', 'Translumina GmbH (Germany)', 'Elixir Medical Corporation (US)', 'Vascular Concepts (India)', 'Alvimedica (Turkey)', 'InspireMD Inc. (US)', 'Comed B.V. (Netherlands)'

The rising incidence of cardiovascular diseases, including coronary artery disease, is a major driver for the global coronary stent market. Lifestyle changes, unhealthy diets, and sedentary lifestyles contribute to the growing burden of cardiovascular diseases globally.

Shift towards Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures, including percutaneous coronary intervention (PCI), which drives the demand for coronary stents. Minimally invasive procedures offer benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications compared to traditional open-heart surgeries.

The dominating region in the global coronary stent market is North America, which holds a significant market share. With the presence of renowned casinos in Las Vegas and Atlantic City, North America has established itself as a gambling hub. The region boasts a thriving casino industry and is home to several major players in the gaming equipment market. The demand for cutting-edge gaming machines, electronic gaming tables, and other equipment is consistently high in this region, driving the growth of the market. North America's market share is estimated to be around 40%, making it a key player in the global Coronary Stent market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Coronary Stent Market

Report ID: SQMIG35A2668

$5,300
BUY NOW GET FREE SAMPLE